NEUNEUREN PHARMACEUTICALS LIMITEDMarket sensitive

FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE

Date and time
Announcement type
Company Update

More from Health Care

More News

ARLCompany Update12 November 2026

Ardea Resources (ASX: ARL) Scandium Study Models US$510m NPV